CoAxia Raises $21.5 Million
CoAxia Inc., a Maple Gove, Minn.-based developer of perfusion augmentation therapies to improve outcomes for patients with cerebral ischemia resulting from stroke, has raised $21.5 million in Series D funding. Sofinnova Partners led the round, and was joined by return backers Affinity Capital Management, Baird Venture Partners, Canaan Ventures Partners, Johnson and Johnson Development Corp. and Prism Ventureworks. The company had previously raised around $52 million.
23 June 2009•4 mins read
